$AC
Associated Capital Group, Inc.

2023 Q4 Form 10-K Financial Statement

#000143774924008882 Filed on March 21, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $5.636M $12.68M
YoY Change -25.23% -16.71%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.180M $22.69M
YoY Change -2.06% 20.17%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $60.00K $360.0K
YoY Change -33.33% 5.57%
% of Gross Profit
Operating Expenses $10.46M $29.63M
YoY Change 2.99% 11.85%
Operating Profit -$16.95M
YoY Change 50.48%
Interest Expense $29.09M $67.83M
YoY Change 36.79% 31302.31%
% of Operating Profit
Other Income/Expense, Net -$2.413M -$4.017M
YoY Change 40.86% -91.84%
Pretax Income $21.85M $46.87M
YoY Change 29.03% -177.51%
Income Tax $5.551M $9.137M
% Of Pretax Income 25.41% 19.5%
Net Earnings $16.34M $37.45M
YoY Change 19.6% -176.58%
Net Earnings / Revenue 289.96% 295.29%
Basic Earnings Per Share $1.72
Diluted Earnings Per Share $0.76 $1.72
COMMON SHARES
Basic Shares Outstanding 21.77K
Diluted Shares Outstanding 21.77K

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $406.6M $406.6M
YoY Change 0.54% 0.54%
Cash & Equivalents $406.6M $406.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $30.27M $30.27M
Other Receivables $5.587M $5.587M
Total Short-Term Assets $442.5M $442.5M
YoY Change 4.64% 4.64%
LONG-TERM ASSETS
Property, Plant & Equipment $16.50M $16.50M
YoY Change -2.08% -2.08%
Goodwill $3.519M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $466.3M $466.3M
YoY Change 209.84% -1.27%
Other Assets
YoY Change
Total Long-Term Assets $501.3M $501.3M
YoY Change -0.7% -0.7%
TOTAL ASSETS
Total Short-Term Assets $442.5M $442.5M
Total Long-Term Assets $501.3M $501.3M
Total Assets $943.8M $943.8M
YoY Change 1.74% 1.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.459M $4.459M
YoY Change -42.72% -42.72%
Accrued Expenses $20.34M $20.34M
YoY Change 22.23% 22.23%
Deferred Revenue
YoY Change
Short-Term Debt $5.918M $5.918M
YoY Change 105.92% 105.92%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $30.72M $30.72M
YoY Change 12.52% 12.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $30.72M $30.72M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $36.82M $36.82M
YoY Change 34.87% -1.79%
SHAREHOLDERS EQUITY
Retained Earnings $48.23M
YoY Change 218.86%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $907.0M $907.0M
YoY Change
Total Liabilities & Shareholders Equity $943.8M $943.8M
YoY Change 1.74% 1.74%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $16.34M $37.45M
YoY Change 19.6% -176.58%
Depreciation, Depletion And Amortization $60.00K $360.0K
YoY Change -33.33% 5.57%
Cash From Operating Activities -$49.73M $145.1M
YoY Change 24.33% -305.63%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $3.452M $5.752M
YoY Change 2186.09% 1330.85%
Cash From Investing Activities $3.452M $5.752M
YoY Change 2186.09% 1330.85%
FINANCING ACTIVITIES
Cash Dividend Paid $4.346M
YoY Change -1.27%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.139M -$25.04M
YoY Change -80.65% -32.65%
NET CHANGE
Cash From Operating Activities -49.73M $145.1M
Cash From Investing Activities 3.452M $5.752M
Cash From Financing Activities -6.139M -$25.04M
Net Change In Cash -52.41M $125.8M
YoY Change -26.77% -217.2%
FREE CASH FLOW
Cash From Operating Activities -$49.73M $145.1M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4054565
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3601877
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
943797000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
927690000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023 ac Number Of Stock Award And Incentive Plans
NumberOfStockAwardAndIncentivePlans
1 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-37387
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3965991
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
191 Mason Street
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Greenwich
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06830
CY2023 dei City Area Code
CityAreaCode
203
CY2023 dei Local Phone Number
LocalPhoneNumber
629-9595
CY2023 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.001 per share
CY2023 dei Trading Symbol
TradingSymbol
AC
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
105000000 usd
CY2023 dei Auditor Firm
AuditorFirmId
34
CY2023 dei Auditor Name
AuditorName
Deloitte & Touche, LLP
CY2023 dei Auditor Location
AuditorLocation
Stamford, Connecticut
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12683000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15228000 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
17246000 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
18883000 usd
CY2023 us-gaap Management Fee Expense
ManagementFeeExpense
5446000 usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
0 usd
CY2023 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-6938000 usd
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-7607000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
29630000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
26490000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-16947000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-11262000 usd
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
43033000 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
-56513000 usd
CY2023 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
25258000 usd
CY2022 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
10653000 usd
CY2023 us-gaap Interest Expense
InterestExpense
462000 usd
CY2022 us-gaap Interest Expense
InterestExpense
216000 usd
CY2023 ac Shareholderdesignated Contribution
ShareholderdesignatedContribution
4017000 usd
CY2022 ac Shareholderdesignated Contribution
ShareholderdesignatedContribution
3127000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
63812000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-49203000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
46865000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-60465000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9137000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-14943000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
37728000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-45522000 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
277000 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3385000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
37451000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-48907000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.72
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.22
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.72
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.22
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21771
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22024
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21771
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22024
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21538
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21990
CY2023 us-gaap Profit Loss
ProfitLoss
37728000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-45522000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
277000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3385000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37451000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48907000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
317487000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
218462000 usd
CY2023Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
89155000 usd
CY2022Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
186001000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
196583000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
195585000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
142974000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
150498000 usd
CY2023Q4 ac Receivable From Brokerdealer And Clearing Organization Net Of Cash Withheld For Real Estate
ReceivableFromBrokerdealerAndClearingOrganizationNetOfCashWithheldForRealEstate
16005000 usd
CY2022Q4 ac Receivable From Brokerdealer And Clearing Organization Net Of Cash Withheld For Real Estate
ReceivableFromBrokerdealerAndClearingOrganizationNetOfCashWithheldForRealEstate
12072000 usd
CY2023Q4 ac Receivable From Brokerdealer And Clearing Organization Cash Held For Real Estate
ReceivableFromBrokerdealerAndClearingOrganizationCashHeldForRealEstate
14263000 usd
CY2022Q4 ac Receivable From Brokerdealer And Clearing Organization Cash Held For Real Estate
ReceivableFromBrokerdealerAndClearingOrganizationCashHeldForRealEstate
0 usd
CY2023Q4 ac Investment Advisory Fees Receivable
InvestmentAdvisoryFeesReceivable
4711000 usd
CY2022Q4 ac Investment Advisory Fees Receivable
InvestmentAdvisoryFeesReceivable
3807000 usd
CY2023Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
8474000 usd
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
10320000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
3519000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
3519000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
22999000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
18699000 usd
CY2023Q4 us-gaap Assets
Assets
943797000 usd
CY2022Q4 us-gaap Assets
Assets
927690000 usd
CY2023Q4 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
4459000 usd
CY2022Q4 srt Payables To Broker Dealers And Clearing Organizations
PayablesToBrokerDealersAndClearingOrganizations
7784000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
15169000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
13936000 usd
CY2023Q4 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
5918000 usd
CY2022Q4 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
2874000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5173000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2707000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
30719000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
27301000 usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
6103000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
10193000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
999047000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
999047000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
48231000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15126000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
140328000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
124002000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
906975000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
890196000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
890196000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-0 usd
CY2023Q1 ac Net Income Loss Including Portion Attributable To Noncontrolling Interests
NetIncomeLossIncludingPortionAttributableToNoncontrollingInterests
17754000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1949000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
906001000 usd
CY2023Q2 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-0 usd
CY2023Q2 ac Net Income Loss Including Portion Attributable To Noncontrolling Interests
NetIncomeLossIncludingPortionAttributableToNoncontrollingInterests
3371000 usd
CY2023Q2 us-gaap Dividends
Dividends
2188000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7617000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
899567000 usd
CY2023Q3 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-0 usd
CY2023Q3 ac Net Income Loss Including Portion Attributable To Noncontrolling Interests
NetIncomeLossIncludingPortionAttributableToNoncontrollingInterests
-16000 usd
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3815000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
895736000 usd
CY2023Q4 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
0 usd
CY2023Q4 ac Net Income Loss Including Portion Attributable To Noncontrolling Interests
NetIncomeLossIncludingPortionAttributableToNoncontrollingInterests
16342000 usd
CY2023Q4 us-gaap Dividends
Dividends
2158000 usd
CY2023Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2945000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
906975000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
935346000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-0 usd
CY2022Q1 ac Net Income Loss Including Portion Attributable To Noncontrolling Interests
NetIncomeLossIncludingPortionAttributableToNoncontrollingInterests
-15989000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
293000 usd
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
876000 usd
CY2022Q1 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
0 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
918188000 usd
CY2022Q2 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-0 usd
CY2022Q2 ac Net Income Loss Including Portion Attributable To Noncontrolling Interests
NetIncomeLossIncludingPortionAttributableToNoncontrollingInterests
-29804000 usd
CY2022Q2 us-gaap Dividends
Dividends
2203000 usd
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1317000 usd
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
993000 usd
CY2022Q2 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
-0 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
885857000 usd
CY2022Q3 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-0 usd
CY2022Q3 ac Net Income Loss Including Portion Attributable To Noncontrolling Interests
NetIncomeLossIncludingPortionAttributableToNoncontrollingInterests
-16498000 usd
CY2022Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
441000 usd
CY2022Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
13205000 usd
CY2022Q3 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
2868000 usd
CY2022Q3 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
-0 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
879255000 usd
CY2022Q4 ac Net Income Loss Including Portion Attributable To Noncontrolling Interests
NetIncomeLossIncludingPortionAttributableToNoncontrollingInterests
13664000 usd
CY2022Q4 us-gaap Dividends
Dividends
2199000 usd
CY2022Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
524000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
890196000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
37728000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-45522000 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5502000 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1895000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
360000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
341000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-914000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-14211000 usd
CY2023 us-gaap Noncash Contribution Expense
NoncashContributionExpense
1158000 usd
CY2022 us-gaap Noncash Contribution Expense
NoncashContributionExpense
711000 usd
CY2023 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
30494000 usd
CY2022 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-64078000 usd
CY2023 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-0 usd
CY2022 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-3634000 usd
CY2023 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
3964000 usd
CY2022 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
12846000 usd
CY2023 us-gaap Increase Decrease In Debt Securities Trading
IncreaseDecreaseInDebtSecuritiesTrading
-125899000 usd
CY2022 us-gaap Increase Decrease In Debt Securities Trading
IncreaseDecreaseInDebtSecuritiesTrading
92484000 usd
CY2023 ac Increase Decrease In Contributions To Partnerships
IncreaseDecreaseInContributionsToPartnerships
3590000 usd
CY2022 ac Increase Decrease In Contributions To Partnerships
IncreaseDecreaseInContributionsToPartnerships
7510000 usd
CY2023 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
16616000 usd
CY2022 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
10643000 usd
CY2023 us-gaap Increase Decrease In Due From Affiliates Current
IncreaseDecreaseInDueFromAffiliatesCurrent
-1641000 usd
CY2022 us-gaap Increase Decrease In Due From Affiliates Current
IncreaseDecreaseInDueFromAffiliatesCurrent
-2511000 usd
CY2023 us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
-8567000 usd
CY2022 us-gaap Increase Decrease In Brokerage Receivables
IncreaseDecreaseInBrokerageReceivables
-23667000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
904000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4462000 usd
CY2023 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-2760000 usd
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2644000 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4660000 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2609000 usd
CY2023 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-3325000 usd
CY2022 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-1555000 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2040000 usd
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1233000 usd
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-5794000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2466000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-497000 usd
CY2023 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
107347000 usd
CY2022 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-25030000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
145075000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70552000 usd
CY2023 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1486000 usd
CY2022 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
8462000 usd
CY2023 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
5975000 usd
CY2022 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
2940000 usd
CY2023 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1263000 usd
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2329000 usd
CY2023 ac Proceeds Payments For Divesture Of Interest In Subsidiaries And Affiliates
ProceedsPaymentsForDivestureOfInterestInSubsidiariesAndAffiliates
0 usd
CY2022 ac Proceeds Payments For Divesture Of Interest In Subsidiaries And Affiliates
ProceedsPaymentsForDivestureOfInterestInSubsidiariesAndAffiliates
-1471000 usd
CY2023 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
0 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
5066000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5752000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
402000 usd
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
4346000 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
4402000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16326000 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2575000 usd
CY2023 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
4367000 usd
CY2022 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
30198000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-25039000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37175000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
125788000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-107325000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
221269000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
328594000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
347057000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
221269000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
462000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
216000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7200000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4024000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
317487000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
218462000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7866000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2807000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
347057000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
221269000 usd
CY2015Q4 ac Number Of Shares Purchased In Spinoff
NumberOfSharesPurchasedInSpinoff
4393055
CY2015Q4 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
150000000 usd
CY2023Q4 ac Number Of Shares Held
NumberOfSharesHeld
2386295
CY2022Q4 ac Number Of Shares Held
NumberOfSharesHeld
2407000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported on the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17965000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17955000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1462000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1102000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16503000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16853000 usd
CY2023Q4 ac Management Fee Expense Percentage
ManagementFeeExpensePercentage
0.10 pure
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Concentration of Credit Risk</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and receivables from brokers. The Company maintains cash and cash equivalents primarily in the Gabelli U.S. Treasury Money Market Fund, which invests fully in instruments issued by the U.S. government. Receivables from brokers and financial institutions can exceed the federally insured limit. The concentration of credit risk with respect to advisory fees and incentive fees, which are included in investment advisory fees receivable and receivables from affiliates on the consolidated statements of financial condition, is generally limited due to the short payment terms extended to clients by the Company. All investments in securities are held at <em style="font: inherit;">third</em> party brokers or custodians.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p>
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12683000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15228000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
204001000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
196583000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
228697000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
195585000 usd
CY2023Q4 us-gaap Debt Securities Trading And Equity Securities Fv Ni Cost
DebtSecuritiesTradingAndEquitySecuritiesFvNiCost
292301000 usd
CY2023Q4 us-gaap Trading Securities
TradingSecurities
285738000 usd
CY2022Q4 us-gaap Debt Securities Trading And Equity Securities Fv Ni Cost
DebtSecuritiesTradingAndEquitySecuritiesFvNiCost
413333000 usd
CY2022Q4 us-gaap Trading Securities
TradingSecurities
381586000 usd
CY2023Q4 ac Investment Sold Not Yet Purchased Cost
InvestmentSoldNotYetPurchasedCost
5858000 usd
CY2023Q4 us-gaap Investment Sold Not Yet Purchased At Fair Value
InvestmentSoldNotYetPurchasedAtFairValue
5918000 usd
CY2022Q4 ac Investment Sold Not Yet Purchased Cost
InvestmentSoldNotYetPurchasedCost
3417000 usd
CY2022Q4 us-gaap Investment Sold Not Yet Purchased At Fair Value
InvestmentSoldNotYetPurchasedAtFairValue
2874000 usd
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
107400000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
114700000 usd
CY2023Q4 ac Investments In Unaffiliated Entities
InvestmentsInUnaffiliatedEntities
35600000 usd
CY2022Q4 ac Investments In Unaffiliated Entities
InvestmentsInUnaffiliatedEntities
35800000 usd
CY2022Q4 ac Direct Investment In Partnership And Variable Interest Entity
DirectInvestmentInPartnershipAndVariableInterestEntity
4000000 usd
ac Partnership And Vie Investment Percentage
PartnershipAndVieInvestmentPercentage
1 pure
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
317487000 usd
CY2023Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
89155000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
196583000 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
126751000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
142974000 usd
CY2023Q4 us-gaap Receivables From Brokers Dealers And Clearing Organizations
ReceivablesFromBrokersDealersAndClearingOrganizations
30268000 usd
CY2023Q4 ac Investment Advisory Fees Receivable
InvestmentAdvisoryFeesReceivable
4711000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
35868000 usd
CY2023Q4 us-gaap Assets
Assets
943797000 usd
CY2023Q4 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
5918000 usd
CY2023Q4 ac Payable To Brokers And Other Liabilities
PayableToBrokersAndOtherLiabilities
24801000 usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
6103000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
906975000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
943797000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
218462000 usd
CY2022Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
186001000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
195585000 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
126210000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
150498000 usd
CY2022Q4 us-gaap Receivables From Brokers Dealers And Clearing Organizations
ReceivablesFromBrokersDealersAndClearingOrganizations
12072000 usd
CY2022Q4 ac Investment Advisory Fees Receivable
InvestmentAdvisoryFeesReceivable
3807000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
35055000 usd
CY2022Q4 us-gaap Assets
Assets
927690000 usd
CY2022Q4 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
2874000 usd
CY2022Q4 ac Payable To Brokers And Other Liabilities
PayableToBrokersAndOtherLiabilities
24427000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
10193000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
890196000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
927690000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12683000 usd
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
29630000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-16947000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
63812000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
46865000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9137000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
37728000 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
277000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
37451000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15228000 usd
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
26490000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-11262000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-49203000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-60465000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-14943000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-45522000 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3385000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-48907000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
13774000 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
10600000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
-34000 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
27000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
1000000 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
5900000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
4130000 usd
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
2753000 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
10610000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
13774000 usd
CY2023 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-34000 usd
CY2022 us-gaap Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
27000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
9528000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-348000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1566000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-13237000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
471000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-463000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-57000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-925000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
52000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
41000 usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-2423000 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-11000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9137000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-14943000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.008 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.017 pure
CY2023 ac Effective Income Tax Rate Reconciliation Credit Deduction Dividend Percent
EffectiveIncomeTaxRateReconciliationCreditDeductionDividendPercent
-0.009 pure
CY2022 ac Effective Income Tax Rate Reconciliation Credit Deduction Dividend Percent
EffectiveIncomeTaxRateReconciliationCreditDeductionDividendPercent
0.006 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.01 pure
CY2023 ac Effective Income Tax Rate Reconciliation Foreign Investment Percent
EffectiveIncomeTaxRateReconciliationForeignInvestmentPercent
-0.062 pure
CY2022 ac Effective Income Tax Rate Reconciliation Foreign Investment Percent
EffectiveIncomeTaxRateReconciliationForeignInvestmentPercent
0 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.021 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0 pure
CY2023 ac Effective Income Tax Rate Reconciliation Intangible Percent
EffectiveIncomeTaxRateReconciliationIntangiblePercent
0.001 pure
CY2022 ac Effective Income Tax Rate Reconciliation Intangible Percent
EffectiveIncomeTaxRateReconciliationIntangiblePercent
0.009 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
0.016 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
0.006 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.021 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.001 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.011 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.01 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.195 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247 pure
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
794000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1073000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
409000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
542000 usd
CY2023Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
5085000 usd
CY2022Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
4660000 usd
CY2023Q4 ac Deferred Tax Assets Shareholder Designated Contribution
DeferredTaxAssetsShareholderDesignatedContribution
1842000 usd
CY2022Q4 ac Deferred Tax Assets Shareholder Designated Contribution
DeferredTaxAssetsShareholderDesignatedContribution
1902000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
64000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
45000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9145000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8233000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
227000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
221000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
227000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
221000 usd
CY2023Q4 ac Gross Deferred Tax Liabilities Before Valuation Allowances
GrossDeferredTaxLiabilitiesBeforeValuationAllowances
-8918000 usd
CY2022Q4 ac Gross Deferred Tax Liabilities Before Valuation Allowances
GrossDeferredTaxLiabilitiesBeforeValuationAllowances
-8012000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
350000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
336000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
8568000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7676000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
350000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
336000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023 us-gaap Profit Loss
ProfitLoss
37728000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-45522000 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
277000 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3385000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
37451000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-48907000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21771
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22024
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21771
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22024
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.72
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.22
CY2023Q4 ac Ownership Percentage Of Voting Rights
OwnershipPercentageOfVotingRights
0.96 pure
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
107400000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
114700000 usd
CY2023 ac Notice Period For Termination Of Agreement
NoticePeriodForTerminationOfAgreement
P30D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2017Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
500000
CY2017Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1000000
CY2018Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
500000
CY2021Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
677144
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
67792
CY2022 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
37.98
CY2022Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
609352
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
452688
CY2023 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
36.06
CY2023Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
156664
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
16300000 usd
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2600000 usd
CY2023 us-gaap Dividends
Dividends
4300000 usd
CY2022 us-gaap Dividends
Dividends
4400000 usd
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
8000 usd
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
8000 usd
CY2023 ac Shareholderdesignated Contribution
ShareholderdesignatedContribution
4000000 usd
CY2022 ac Shareholderdesignated Contribution
ShareholderdesignatedContribution
3100000 usd
CY2023Q4 ac Liability For Shareholder Designated Contribution Program
LiabilityForShareholderDesignatedContributionProgram
2800000 usd
CY2022Q4 ac Liability For Shareholder Designated Contribution Program
LiabilityForShareholderDesignatedContributionProgram
1000000 usd

Files In Submission

Name View Source Status
0001437749-24-008882-index-headers.html Edgar Link pending
0001437749-24-008882-index.html Edgar Link pending
0001437749-24-008882.txt Edgar Link pending
0001437749-24-008882-xbrl.zip Edgar Link pending
ac-20231231.xsd Edgar Link pending
ac20231231_10k.htm Edgar Link pending
ex_596604.htm Edgar Link pending
ex_596605.htm Edgar Link pending
ex_596606.htm Edgar Link pending
ex_596608.htm Edgar Link pending
ex_596609.htm Edgar Link pending
ex_637764.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
ac-20231231_cal.xml Edgar Link unprocessable
ac-20231231_lab.xml Edgar Link unprocessable
ac-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ac20231231_10k_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ac-20231231_def.xml Edgar Link unprocessable